Home › Trial NCT01169012
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
- Trial IDNCT01169012
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorUNC Lineberger Comprehensive Cancer Center
- Enrollment13
- Start date2010-09
- ConditionsMyelodysplastic Syndrome · Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Chronic Myelomonocytic Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.